Oct. 29, 2012 - At the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO, Boston, Mass.), Elekta announced that MOSAIQ Oncology Information System (OIS) v 2.50 now includes connectivity with Nucletron's microSelectron® Digital afterloader. This added connectivity allows the treatment record and chart information, in addition to dose and structure sets, to be part of the complete patient record – saving time, simplifying workflow and creating a paperless flow of brachytherapy practice information.

MOSAIQ-microSelectron Digital connectivity is the latest in Elekta's long history of providing interfaces with virtually any radiotherapy delivery device or treatment planning system.

MOSAIQ now integrates with Accuray CyberKnife system 
Recently, St. Anthony Hospital (Oklahoma City, Okla.) became the first center to use a MOSAIQ interface for its Accuray CyberKnife radiosurgery system. A MOSAIQ user for several years, St. Anthony officials had discussed the possibility of a MOSAIQ interface for CyberKnife with Accuray representatives.

"We are always trying to pursue opportunities to improve the communication capabilities of our interfaces," says Chad Crane, BSRT(T), St. Anthony Supervisor, Radiation Oncology. "Since MOSAIQ is our primary department EMR, to have that functionality added to it was something we wanted to participate in."

According to St. Anthony Lead Physicist, Cindy Parry, M.S., the MOSAIQ-CyberKnife interface presented an opportunity to streamline their radiosurgery process and to consolidate all patient information in a single location.

"To me, the greatest value is that the treatment is directly transferred to MOSAIQ through the interface," she adds. "In this way, the physician seeing a patient for follow up can readily note that a CyberKnife patient got his fractions done in x amount of time, or can see if this patient also had an HDR or linac treatment – all that information will be in the patient record for him to see at once."

Mevion proton delivery added to MOSAIQ connectivity portfolio
Elekta also reported in October that MOSAIQ now includes interconnectivity with Mevion Medical Systems' MEVION S250 proton therapy system.

"The integration of the MEVION S250 with MOSAIQ is another important step toward making proton therapy accessible to more patients," says Lionel G. Bouchet, Ph.D., Senior Director Product Management, Mevion Medical Systems.

More than 20 years of open-vendor connectivity
With a longstanding open-systems development philosophy, MOSAIQ includes interfaces to Elekta's portfolio of linear accelerators, Elekta's Leksell Gamma Knife® Perfexion, and a broad array of third-party delivery systems, including Varian's TrueBeam, Accuray's TomoTherapy system, and Siemens' Artiste and ONCOR systems, in addition to many other commercially available radiotherapy systems.

"With the latest additions to the MOSAIQ interface portfolio, Elekta maintains its ongoing commitment to develop seamless MOSAIQ connectivity for any treatment system or treatment planning system," says Todd Powell, Executive Vice President, Elekta Software. "We match this effort with our constant introduction of new and clinically useful MOSAIQ functionality that health care providers can harness to improve the patient experience."

More than 2,500 global customers count on Elekta software to help them provide the safest and most efficient treatments in the fight against cancer. From its multiple redundant safety features to industry-leading practice management capabilities, MOSAIQ is the tool of choice to manage cutting-edge treatment centers.

For more information: www.elekta.com


Related Content

News | Proton Therapy

September 28, 2023 — Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, will ...

Time September 28, 2023
arrow
News | Radiation Therapy

September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...

Time September 28, 2023
arrow
News | Radiopharmaceuticals and Tracers

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
arrow
News | Radiation Therapy

September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...

Time September 27, 2023
arrow
News | Mammography

September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently ...

Time September 26, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
Subscribe Now